Literature DB >> 29535237

Greater Occipital Nerve Block for Acute Treatment of Migraine Headache: A Large Retrospective Cohort Study.

Sorcha M Allen1, Farouk Mookadam1, Stephen S Cha1, John A Freeman1, Amaal J Starling1, Martina Mookadam2.   

Abstract

INTRODUCTION: Greater occipital nerve (GON) blocks are frequently used to treat migraine headaches, although a paucity of supporting clinical evidence exists. The objective of this study was to assess the efficacy of GON block in acute treatment of migraine headache, with a focus on pain relief.
METHODS: This retrospective cohort study was undertaken between January 2009 and August 2014 and included patients who underwent at least 1 GON block and attended at least 1 follow-up appointment. Change in the 11-point numeric pain rating scale (NPRS) was used to assess the response to GON block. Response was defined as "minimal" (<30% NPRS point reduction), "moderate" (31-50% NPRS point reduction), or "significant" (>50% NPRS point reduction).
RESULTS: A total of 562 patients met inclusion criteria; 423 were women (75%). Mean age was 58.6 ± 16.7 years. Of these 562, 459 patients (82%) rated their response to GON block as moderate or significant. No statistically significant relationship existed between previous treatment regimens and response to GON block. GON block was equally effective across the different age and sex groups.
CONCLUSIONS: Greater occipital block seems to be an effective option for acute management of migraine headache, with promising reductions in pain scores. © Copyright 2018 by the American Board of Family Medicine.

Entities:  

Keywords:  Migraine Headache; Nerve Block; Pain; Retrospective Studies; Treatment Outcome

Mesh:

Substances:

Year:  2018        PMID: 29535237     DOI: 10.3122/jabfm.2018.02.170188

Source DB:  PubMed          Journal:  J Am Board Fam Med        ISSN: 1557-2625            Impact factor:   2.657


  7 in total

1.  Prevalence of Occipital Neuralgia at a Community Hospital-based Headache Clinic.

Authors:  Paul G Mathew; Umer Najib; Shaoleen Khaled; Regina Krel
Journal:  Neurol Clin Pract       Date:  2021-02

Review 2.  Non-invasive neuromodulation in the acute treatment of migraine: a systematic review and meta-analysis of randomized controlled trials.

Authors:  Oliver Clark; Areej Mahjoub; Nily Osman; Ann-Marie Surmava; Saber Jan; Ana Marissa Lagman-Bartolome
Journal:  Neurol Sci       Date:  2021-10-26       Impact factor: 3.307

3.  Comparing the injectate spread and nerve involvement between different injectate volumes for ultrasound-guided greater occipital nerve block at the C2 level: a cadaveric evaluation.

Authors:  In Chan Baek; Kyungeun Park; Tae Lim Kim; Jehoon O; Hun-Mu Yang; Shin Hyung Kim
Journal:  J Pain Res       Date:  2018-09-25       Impact factor: 3.133

Review 4.  Mechanisms of migraine as a chronic evolutive condition.

Authors:  Anna P Andreou; Lars Edvinsson
Journal:  J Headache Pain       Date:  2019-12-23       Impact factor: 7.277

Review 5.  Interventional Procedures in Episodic Migraine.

Authors:  Brian M Plato; Mandy Whitt
Journal:  Curr Pain Headache Rep       Date:  2020-11-12

Review 6.  Ultrasonography-Guided Common Musculoskeletal Interventions from Head to Toe: Procedural Tips for General Radiologists.

Authors:  Roland White; Michael Croft; Stephen Bird; Matthew Sampson
Journal:  Korean J Radiol       Date:  2021-08-31       Impact factor: 3.500

7.  Real-time ultrasound-guided stellate ganglion block for migraine: an observational study.

Authors:  Zhiqiang Lu; Junzhen Wu; Jiawei Hou; Shaofeng Pu; Xingguo Xu
Journal:  BMC Anesthesiol       Date:  2022-03-24       Impact factor: 2.217

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.